Ikon Gel contains Fluconazole 0.5% w/w, an antifungal agent belonging to the triazole class, indicated for the topical treatment of superficial fungal infections of the skin. Fluconazole exerts its antifungal effect by inhibiting the fungal cytochrome P450 enzyme 14α-demethylase, which is essential for the conversion of lanosterol to ergosterol, a critical component of the fungal cell membrane. Disruption of ergosterol synthesis compromises membrane integrity, leading to increased permeability and ultimately fungal cell death. Ikon Gel is primarily used to manage dermatophytosis, candidiasis, and other superficial mycoses caused by susceptible strains of fungi. The gel formulation allows for targeted application, promoting effective local drug concentration with minimal systemic absorption, thereby reducing the risk of systemic side effects. It is generally well tolerated; however, patients may occasionally experience mild local reactions such as erythema, itching, or burning at the application site. Ikon Gel should be applied once or twice daily to the affected area, following proper skin hygiene, for the duration prescribed by a healthcare professional. Use is contraindicated in individuals with known hypersensitivity to Fluconazole or any component of the formulation. Caution is advised in pregnant or breastfeeding women, and consultation with a healthcare provider is recommended before use.